Name: Using AI to make a big impact for emerging and mid-sized biopharma companies
Start: 2021-04-29T14:00:00Z
End: 2021-04-29T14:59:48.000Z
Location: BrightTALK
Rating: 5

pharmaphorum provides a digital podium for communicating thought leadership and innovation within pharma. Our webinars bring together different stakeholders from across the healthcare spectrum to drive fresh thinking and novel solutions that deliver better outcomes for patients.

In this webinar, sponsored by IQVIA, speakers from The Medical Informatics Group at the University Hospital Frankfurt and the Collaboration on Rare Diseases in Medical Informatics project, Germany will discuss the potential of medical informatics in rare disease research and treatment. They will also provide insight into current problems, future challenges and new ideas across the bridge between rare diseases and medical informatics.

Medical Informatics and Rare Disease: a bridge between two worlds

Join us on Tuesday 26th April for a webinar, bought to you in association with IQVIA, where key industry figures from IQVIA and Boehringer Ingelheim, along with Integrated Care System Strategy experts, will be discussing the future of the Health and Care Bill and the importance of collaborations between ICS leaders to address system readiness to improve population health.

ICSs - an opportunity to improve Patient & Market Access at a local level

In today’s competitive global market, pharmaceutical companies cannot afford to waste time or resources on strategies that do not fit patient needs or generate scripts. Interconnectivity between all stakeholders and a 360° view of everything that touches the patient are essential when mapping each patient’s and HCP’s unique and differentiated journey. But how do you ensure you are making the right connections and ensuring all key stakeholders have access to tailored education around treatments?  

In this webinar, brought to you by EVERSANA™, digital communication and design experts will dive into the history of digital communication in healthcare — and how digital channels are changing how pharma interacts with stakeholders

Is your digital communication strategy up to par?

Although resources exist for digital health entrepreneurs looking to raise their first key investment round, industry advice on next steps is harder to find. The growth of a start-up after obtaining Series A funding is a transformational phase when scaling up the company becomes critical. The CEO can experience pressure to deliver on the revenue growth goals, whilst still developing their product, growing the team, and implementing core processes for the company. 

In this webinar, we will discuss the challenges CEOs face and their personal journey during this exciting stage of entrepreneurship. Panel discussions will be based around the recent publication The Digital Health Start-up Journey: From Series A to scaling up.

The Digital Health Start-up Journey: Series A to scale-up

The primary care setting offers huge potential for commercial research. This was, and still is being, demonstrated through the UK’s COVID-19 vaccine research successes.  But tapping into that potential requires companies to understand and to plan for primary care. In this session, we will unpick some of the common challenges faced by companies when initiating research in this setting.

Conducting successful commercial research in a primary care setting

In this webinar, speakers from the NIHR and Roche will discuss what data is available to life science companies and CROs, how it’s currently being used for research planning and placement, and what more could be done with that data. They’ll also look at what culture and process changes will be required to make sure this data can be readily translated into insights to improve commercial research delivery.

Unlocking the potential of healthcare data for commercial clinical research

In a fireside chat hosted by pharmaphorum’s Jonah Comstock, Healthware Group CEO Roberto Ascione (author of the recent book “The Future of Health”) and Politecnico di Milano Professor Emanuele Lettieri will discuss recent trends in digital transformation in healthcare and life sciences that prompted the creation of the Programme as well as share a little about the programme itself. Comstock, Ascione, and Lettieri will discuss each of the modules mentioned above and dive into what innovators can do to prepare their organisations to meet this exciting future.

Preparing industry leaders for digital transformation

Synthetic Control Arms (SCAs) have the potential to reduce the number of trial participants, eliminate delays, and lower costs. In this webinar experts from the worlds of clinical trials and clinical AI will present and discuss the factors to consider when planning to use an SCA as part of a clinical trial.

How can synthetic control arms & real-world data redefine clinical trial design?

As the COVID-19 pandemic continues to impact the healthcare landscape, and the digital transformation of the life sciences industry gathers pace, what can we expect to see in 2022? 

In this webinar, senior members from Healthware Group discuss the key trends and developments set to shape the industry and present their predictions for the year ahead. Join us on Friday 21 January at 2.00pm CET to find out how life science companies can stay ahead of the competition in 2022.

Plus, webinar attendees will have the opportunity to receive a free copy of the newly published book, “The Future of Health, How Digital Technology Will Make Care Accessible, Sustainable, and Human”, which expands on these topics (while supplies last).

Life Sciences Predictions for 2022

Once widely acknowledged as so special that only scientists and clinical specialists need apply, oncology has become exponentially more clinically targeted and sophisticated over the last decade.
 
Yet how many other therapy areas have market leaders that don’t even have clinical approval in that indication?

Immunotherapies are the scientific answer to cancer, how important is marketing?

This webinar will take place on Tuesday 9th November at 12:00 pm GMT / 1:00 pm CET.

Far more common than initially thought, rare disease treatments remain far too scarce. The answer to the problem, of course, lies in making both academic and commercial medical research more efficient and effective.

This webinar will share more information about how to work more collegially with academics, industry and patient groups to ultimately improve the care and treatment of patients with rare diseases.

Drug development and how best to work with specialised Rare Disease networks

The exact shape of healthcare’s post-COVID ‘new normal’ is still being framed, but it is clear that some trends are already taking shape - and one of the key ones is digital transformation in pharma.

This pharmaphorum webinar, held in association with P360, takes place on Wednesday 19th May 08:00 PST / 16:00 BST / 17:00 CET and will look at the long-term implications of healthcare’s pandemic-powered digital transformation.

The digital transformation of pharma’s physician engagement strategies

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations and is accelerating the development of new and innovative therapies and treatments to improve patient outcomes.

This pharmaphorum webinar, held in association with Savana, will take place on Thursday 22 April from 16:00-17:00 BST / 17:00-18:00 CET / 10:00-11:00 EST and hear from presenters at BREATHE - the Health Data Research Hub for Respiratory Health, Salford Royal NHS Foundation Trust and Savana.

AI, big data and deep real-world evidence – the challenges and opportunities

How healthcare professionals prefer to engage with pharma companies has been changing for some time, and COVID’s digital transformation of society has dramatically accelerated this.

This pharmaphorum webinar – in association with Axtria – will take place on Wednesday 14th April from 16:00-17:00 BST / 11:00-12:00 EDT and look at customer engagement and the future of pharma’s field force.

Customer engagement and pharma’s field force future

Previously viewed as a ‘nice to have’ for the pharma industry, virtual clinical trials were already moving from a theoretical to a practical proposition before COVID-19 accelerated their transition.

This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), will take place on Thursday 25th March 15:30 GMT / 16:30 CET and look at where virtual trials fit into the next generation of commercial clinical research.

Virtual trials and the next generation of pharma clinical research

The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical research at a time of immense pressure and stress on personnel and resources.

This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), will take place on Thursday 25th February 13:00 GMT / 14:00 CET and discuss the UK’s approach to delivering research during the COVID-19 pandemic.

Coordinating and delivering research in the pandemic: The UK approach

Involving patients in clinical trial design can hugely benefit pharmaceutical research's sustainability.

This pharmaphorum webinar, held in association with the National Institute for Health Research (NIHR), takes place on Wednesday 16th December, 11:00 GMT / 12:00 CET and will look at how to navigate the compliance pathway to increase patient engagement with clinical trials.

Navigating the UK regulatory pathway to increase patient engagement with trials

With recent market changes catalysing a rapid shift to an omnichannel approach, life science organisations of every size are racing to adapt their commercial approach to be more relevant, coordinated and personalised to the needs of each HCP. 

Focus
This pharmaphorum webinar, held in association with Aktana, will take place on 29th April 2021 at 15:00 BST / 10:00 EDT.

Using AI to make a big impact for emerging and mid-sized biopharma companies

Aktana

Artificial Intelligence

Data Science

Omnichannel

The medical research community on BrightTALK brings together medical and research professionals. Find relevant webinars on medical research, laboratory science, continuing medical education and more presented by recognized medical researchers. Join the conversation by participating in live webinars and round table discussions on the latest in medical devices, medical research practices and trends in the healthcare industry.

Medical Research

Thousands of healthcare IT professionals compose the health IT community on BrightTALK. Learn alongside them with relevant webinars on healthcare IT compliance, big data in healthcare and IT solutions for healthcare organizations. Join the conversation by asking questions and engaging with other participants during live webinars and organized discussions.

Health IT

Get powerful life science insights from influential experts. Connect with thought leaders and colleagues to get the most up-to-date knowledge on strategies and initiatives to accelerate the transformation of U.S. and global health care from a volume- to value-based marketplace.

Life Sciences

The research and development community on BrightTALK brings together leading professionals in healthcare, technology and manufacturing to present on current topics in their fields. From big data in healthcare to online forensics training and medical research practices, the community is an exceptional resource for those looking to expand their knowledge. Be part of the conversation by joining the community and participating in interactive live webinars.

Research and Development

Get powerful marketing insights for your business. Connect with experts and colleagues to get the most up-to-date knowledge on which marketing strategies and techniques are driving customer and revenue growth.

Marketing

In the business management community, commercial experts will be sharing webinars and videos on an array of subjects. From sales and marketing, to finance, productivity and growth, this content will help you stay up-to-date with the current economic environment and provide timely management insight to drive business growth.

Using AI to make a big impact for emerging and mid-sized biopharma companies

Presented by

About this talk

More from this channel